Statin use and bleeding complications during treatment with vitamin K antagonists: a cohort study in 8188 patients with atrial fibrillation

Nienke van Rein; L.M. Willem; Suzanne C. Cannegieter; Frits R. Rosendaal; Pieter H. Reitsma; J.M. van der Meer

Related publications

Letter2006

The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment

Angelina García, Jeroen F. van der Heijden, Joost C.M. Meijers, Frits R. Rosendaal, Pieter H. Reitsma

Journal of Thrombosis and Haemostasis

Article2018

Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants

Daniele Pastori, Professor Gregory Lip, Alessio Farcomeni, Francesco Del Sole, Angela Sciacqua, Francesco Perticone, Rossella Marcucci, Elisa Grifoni, Pasquale Pignatelli, Francesco Violi, Mirella Saliola, Marco Casciaro, Danilo Menichelli, Francesco Cribari, Alberto Paladino, Rony Gingis, Marta Novo, Vittoria Cammisotto, Cristina Nocella, Simona Bartimoccia, Roberto Carnevale, Tiziana Di Stefano, Patrizia Iannucci, Elio Sabbatini, Luigi Anastasio, Joseph Tassone Eliezer

Article2018

Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation

María José Serna, José Miguel Rivera‐Caravaca, Rocío Gónzález‐Conejero, María Asunción Esteve‐Pastor, Mariano Valdés, Vicente Vicente, Professor Gregory Lip, Vanessa Roldán, Francisco Marı́n

Article2017

Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity‐Weighted Cohort Study

Mette Søgaard, Flemming Skjøth, Jette Nordstrøm Kjældgaard, Professor Gregory Lip, Torben Bjerregaard Larsen

Article2016

Clinical management and outcome of major bleeding in patients on treatment with vitamin K antagonists

Cecilia Becattini, Laura Franco, Luca Masotti, Cinzia Nitti, Sergio Cattinelli, Roberto Cappelli, Giorgia Manina, Rodolfo Sbrojavacca, Fulvio Pomero, Giancarlo Agnelli